Everand Logo

Welcome to Everand!

  • STAT

    Opinion: STAT+: Unmasking the ‘centricity’ illusion in clinical trials

    The glacial pace of change in mechanistic but essential areas of clinical trials undermines the biopharma industry's claims of progress and compassion.
    by Hope Meely May 24, 2024 1 minute
    Source: Joe Raedle/Getty Images

    During my 25 years working in clinical trial operations, I’ve seen the biopharmaceutical world talk a big game about making the

    You’re reading a preview, subscribe to read more.

    More from STAT

    STAT2 min read
    STAT+: Pharmalittle: We’re Reading About An ‘Unaffordable’ Novartis Drug, A Proposed Patent Rule, And More
    In today's Pharmalittle roundup, we're reading about an "unaffordable" Novartis drug, a new patent office rule, and more.
    STAT2 min read
    STAT+: Pharmalittle: We’re Reading About An FDA Meeting On MDMA, A New Obesity Pill, And More
    Structure Therapeutics disclosed that its oral obesity drug helped reduce weight by 6.2% on average in a mid-stage study, exceeding Wall Street expectations.
    STAT2 min read
    STAT+: Pharmalittle: We’re Reading About A Merck Deal, Weight Loss Drugs, And Lots More
    Merck has struck a $1.3 billion deal to buy Eyebiotech, a move that would push the big drugmaker into the large and growing market for eye care.

    Related Books & Audiobooks